Phthalate exposure associated with self-reported diabetes among Mexican women
- Graduate School of Public Health, Medical Sciences Campus, University of Puerto Rico, San Juan, PR (Puerto Rico)
- National Institute of Public Health, Universidad No. 655, Col. Santa Maria Ahuacatitlan, Cerrada los Pinos y Caminera, CP. 62100 Cuernavaca, Morelos (Mexico)
- Departamento de Toxicologia, Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional, Mexico City (Mexico)
- Division of Laboratory Sciences, National Center for Environmental Health, Centers for Disease Control and Prevention, Atlanta, GA (United States)
- Division of International Health, Department of Preventive Medicine, Mount Sinai School of Medicine, NY (United States)
Background: Phthalates are ubiquitous industrial chemicals used as plasticizers in plastics made of polyvinyl chloride (PVC) to confer flexibility and durability. They are also present in products used for personal-care, industry and in medical devices. Phthalates have been associated with several adverse health effects, and recently it has been proposed that exposure to phthalates, could have an effect on metabolic homeostasis. This exploratory cross-sectional study evaluated the possible association between phthalate exposure and self-reported diabetes among adult Mexican women. Methods: As part of an on-going case-control study for breast cancer, only controls were selected, which constituted 221 healthy women matched by age ({+-}5 years) and place of residence with the cases. Women with diabetes were identified by self-report. Urinary concentrations of nine phthalate metabolites were measured by online solid phase extraction coupled to high performance liquid chromatography-isotope-dilution tandem mass spectrometry. Results: Participants with diabetes had significantly higher concentrations of di(2-ethylhexyl) pththalate (DEHP) metabolites: mono(2-ethyl-5-hydroxyhexyl) phthalate (MEHHP), mono(2-ethyl-5-oxohexyl) phthalate (MEOHP) and mono(2-ethyl-5-carboxypentyl) phthalate (MECPP) but lower levels of monobenzyl phthalate (MBzP) a metabolite of benzylbutyl phthalate, compared to participants without diabetes. A marginally significant positive associations with diabetes status were observed over tertiles with MEHHP (OR{sub T3vs.T1}=2.66; 95% CI: 0.97-7.33; p for trend=0.063) and MEOHP (OR{sub T3vs.T1}=2.27; 95% CI; 0.90-5.75; P for trend=0.079) even after adjusting for important confounders. Conclusions: The results suggest that levels of some phthalates may play a role in the genesis of diabetes. - Highlights: {yields} This study evaluated phthalate exposure and diabetes status among Mexican women. {yields} Urinary phthalates metabolite concentrations were used to determine association. {yields} Participants with diabetes had higher concentrations of three DEHP metabolites. {yields} A positive association with diabetes status was found with MEHHP and MEOHP metabolites. {yields} Results suggest phthalate exposure can have a role in diabetes.
- OSTI ID:
- 22143620
- Journal Information:
- Environmental Research, Vol. 111, Issue 6; Other Information: Copyright (c) 2011 Elsevier Science B.V., Amsterdam, The Netherlands, All rights reserved.; Country of input: International Atomic Energy Agency (IAEA); ISSN 0013-9351
- Country of Publication:
- United States
- Language:
- English
Similar Records
Kinetics of di(2-ethylhexyl) phthalate (DEHP) and mono(2-ethylhexyl) phthalate in blood and of DEHP metabolites in urine of male volunteers after single ingestion of ring-deuterated DEHP
Prenatal exposure estimation of BPA and DEHP using integrated external and internal dosimetry: A case study